Global Blood Coagulants Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
1 Market Overview
- 1.1 Product Overview and Scope of Blood Coagulants
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global Blood Coagulants Consumption Value by Type: 2019 Versus 2023 Versus 2030
- 1.3.2 Recombinant Coagulation Factor
- 1.3.3 Plasma Coagulation Factor
- 1.4 Market Analysis by Sale Channel
- 1.4.1 Overview: Global Blood Coagulants Consumption Value by Sale Channel: 2019 Versus 2023 Versus 2030
- 1.4.2 Hospital
- 1.4.3 Pharmacy
- 1.4.4 Other
- 1.5 Global Blood Coagulants Market Size & Forecast
- 1.5.1 Global Blood Coagulants Consumption Value (2019 & 2023 & 2030)
- 1.5.2 Global Blood Coagulants Sales Quantity (2019-2030)
- 1.5.3 Global Blood Coagulants Average Price (2019-2030)
2 Manufacturers Profiles
- 2.1 Pfizer
- 2.1.1 Pfizer Details
- 2.1.2 Pfizer Major Business
- 2.1.3 Pfizer Blood Coagulants Product and Services
- 2.1.4 Pfizer Blood Coagulants Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.1.5 Pfizer Recent Developments/Updates
- 2.2 Bayer
- 2.2.1 Bayer Details
- 2.2.2 Bayer Major Business
- 2.2.3 Bayer Blood Coagulants Product and Services
- 2.2.4 Bayer Blood Coagulants Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.2.5 Bayer Recent Developments/Updates
- 2.3 Novo Nordisk
- 2.3.1 Novo Nordisk Details
- 2.3.2 Novo Nordisk Major Business
- 2.3.3 Novo Nordisk Blood Coagulants Product and Services
- 2.3.4 Novo Nordisk Blood Coagulants Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.3.5 Novo Nordisk Recent Developments/Updates
- 2.4 Takeda
- 2.4.1 Takeda Details
- 2.4.2 Takeda Major Business
- 2.4.3 Takeda Blood Coagulants Product and Services
- 2.4.4 Takeda Blood Coagulants Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.4.5 Takeda Recent Developments/Updates
- 2.5 SOBI
- 2.5.1 SOBI Details
- 2.5.2 SOBI Major Business
- 2.5.3 SOBI Blood Coagulants Product and Services
- 2.5.4 SOBI Blood Coagulants Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.5.5 SOBI Recent Developments/Updates
- 2.6 Octapharma
- 2.6.1 Octapharma Details
- 2.6.2 Octapharma Major Business
- 2.6.3 Octapharma Blood Coagulants Product and Services
- 2.6.4 Octapharma Blood Coagulants Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.6.5 Octapharma Recent Developments/Updates
- 2.7 CSL
- 2.7.1 CSL Details
- 2.7.2 CSL Major Business
- 2.7.3 CSL Blood Coagulants Product and Services
- 2.7.4 CSL Blood Coagulants Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.7.5 CSL Recent Developments/Updates
3 Competitive Environment: Blood Coagulants by Manufacturer
- 3.1 Global Blood Coagulants Sales Quantity by Manufacturer (2019-2024)
- 3.2 Global Blood Coagulants Revenue by Manufacturer (2019-2024)
- 3.3 Global Blood Coagulants Average Price by Manufacturer (2019-2024)
- 3.4 Market Share Analysis (2023)
- 3.4.1 Producer Shipments of Blood Coagulants by Manufacturer Revenue ($MM) and Market Share (%): 2023
- 3.4.2 Top 3 Blood Coagulants Manufacturer Market Share in 2023
- 3.4.2 Top 6 Blood Coagulants Manufacturer Market Share in 2023
- 3.5 Blood Coagulants Market: Overall Company Footprint Analysis
- 3.5.1 Blood Coagulants Market: Region Footprint
- 3.5.2 Blood Coagulants Market: Company Product Type Footprint
- 3.5.3 Blood Coagulants Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global Blood Coagulants Market Size by Region
- 4.1.1 Global Blood Coagulants Sales Quantity by Region (2019-2030)
- 4.1.2 Global Blood Coagulants Consumption Value by Region (2019-2030)
- 4.1.3 Global Blood Coagulants Average Price by Region (2019-2030)
- 4.2 North America Blood Coagulants Consumption Value (2019-2030)
- 4.3 Europe Blood Coagulants Consumption Value (2019-2030)
- 4.4 Asia-Pacific Blood Coagulants Consumption Value (2019-2030)
- 4.5 South America Blood Coagulants Consumption Value (2019-2030)
- 4.6 Middle East and Africa Blood Coagulants Consumption Value (2019-2030)
5 Market Segment by Type
- 5.1 Global Blood Coagulants Sales Quantity by Type (2019-2030)
- 5.2 Global Blood Coagulants Consumption Value by Type (2019-2030)
- 5.3 Global Blood Coagulants Average Price by Type (2019-2030)
6 Market Segment by Sale Channel
- 6.1 Global Blood Coagulants Sales Quantity by Sale Channel (2019-2030)
- 6.2 Global Blood Coagulants Consumption Value by Sale Channel (2019-2030)
- 6.3 Global Blood Coagulants Average Price by Sale Channel (2019-2030)
7 North America
- 7.1 North America Blood Coagulants Sales Quantity by Type (2019-2030)
- 7.2 North America Blood Coagulants Sales Quantity by Sale Channel (2019-2030)
- 7.3 North America Blood Coagulants Market Size by Country
- 7.3.1 North America Blood Coagulants Sales Quantity by Country (2019-2030)
- 7.3.2 North America Blood Coagulants Consumption Value by Country (2019-2030)
- 7.3.3 United States Market Size and Forecast (2019-2030)
- 7.3.4 Canada Market Size and Forecast (2019-2030)
- 7.3.5 Mexico Market Size and Forecast (2019-2030)
8 Europe
- 8.1 Europe Blood Coagulants Sales Quantity by Type (2019-2030)
- 8.2 Europe Blood Coagulants Sales Quantity by Sale Channel (2019-2030)
- 8.3 Europe Blood Coagulants Market Size by Country
- 8.3.1 Europe Blood Coagulants Sales Quantity by Country (2019-2030)
- 8.3.2 Europe Blood Coagulants Consumption Value by Country (2019-2030)
- 8.3.3 Germany Market Size and Forecast (2019-2030)
- 8.3.4 France Market Size and Forecast (2019-2030)
- 8.3.5 United Kingdom Market Size and Forecast (2019-2030)
- 8.3.6 Russia Market Size and Forecast (2019-2030)
- 8.3.7 Italy Market Size and Forecast (2019-2030)
9 Asia-Pacific
- 9.1 Asia-Pacific Blood Coagulants Sales Quantity by Type (2019-2030)
- 9.2 Asia-Pacific Blood Coagulants Sales Quantity by Sale Channel (2019-2030)
- 9.3 Asia-Pacific Blood Coagulants Market Size by Region
- 9.3.1 Asia-Pacific Blood Coagulants Sales Quantity by Region (2019-2030)
- 9.3.2 Asia-Pacific Blood Coagulants Consumption Value by Region (2019-2030)
- 9.3.3 China Market Size and Forecast (2019-2030)
- 9.3.4 Japan Market Size and Forecast (2019-2030)
- 9.3.5 Korea Market Size and Forecast (2019-2030)
- 9.3.6 India Market Size and Forecast (2019-2030)
- 9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
- 9.3.8 Australia Market Size and Forecast (2019-2030)
10 South America
- 10.1 South America Blood Coagulants Sales Quantity by Type (2019-2030)
- 10.2 South America Blood Coagulants Sales Quantity by Sale Channel (2019-2030)
- 10.3 South America Blood Coagulants Market Size by Country
- 10.3.1 South America Blood Coagulants Sales Quantity by Country (2019-2030)
- 10.3.2 South America Blood Coagulants Consumption Value by Country (2019-2030)
- 10.3.3 Brazil Market Size and Forecast (2019-2030)
- 10.3.4 Argentina Market Size and Forecast (2019-2030)
11 Middle East & Africa
- 11.1 Middle East & Africa Blood Coagulants Sales Quantity by Type (2019-2030)
- 11.2 Middle East & Africa Blood Coagulants Sales Quantity by Sale Channel (2019-2030)
- 11.3 Middle East & Africa Blood Coagulants Market Size by Country
- 11.3.1 Middle East & Africa Blood Coagulants Sales Quantity by Country (2019-2030)
- 11.3.2 Middle East & Africa Blood Coagulants Consumption Value by Country (2019-2030)
- 11.3.3 Turkey Market Size and Forecast (2019-2030)
- 11.3.4 Egypt Market Size and Forecast (2019-2030)
- 11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
- 11.3.6 South Africa Market Size and Forecast (2019-2030)
12 Market Dynamics
- 12.1 Blood Coagulants Market Drivers
- 12.2 Blood Coagulants Market Restraints
- 12.3 Blood Coagulants Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
- 13.1 Raw Material of Blood Coagulants and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of Blood Coagulants
- 13.3 Blood Coagulants Production Process
- 13.4 Blood Coagulants Industrial Chain
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 Blood Coagulants Typical Distributors
- 14.3 Blood Coagulants Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
According to our (Global Info Research) latest study, the global Blood Coagulants market size was valued at USD 403.2 million in 2023 and is forecast to a readjusted size of USD 615.2 million by 2030 with a CAGR of 6.2% during review period.
Coagulation is the process, by which blood changes from a liquid to a gel, forming a blood clot. In general terms, coagulation is a process in which the blood forms clots to block and then heal a lesion/wound/cut and stop the bleeding.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
The Global Info Research report includes an overview of the development of the Blood Coagulants industry chain, the market status of Hospital (Recombinant Coagulation Factor, Plasma Coagulation Factor), Pharmacy (Recombinant Coagulation Factor, Plasma Coagulation Factor), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Blood Coagulants.
Regionally, the report analyzes the Blood Coagulants markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Blood Coagulants market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Blood Coagulants market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Blood Coagulants industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Recombinant Coagulation Factor, Plasma Coagulation Factor).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Blood Coagulants market.
Regional Analysis: The report involves examining the Blood Coagulants market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Blood Coagulants market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Blood Coagulants:
Company Analysis: Report covers individual Blood Coagulants manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Blood Coagulants This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Sale Channel (Hospital, Pharmacy).
Technology Analysis: Report covers specific technologies relevant to Blood Coagulants. It assesses the current state, advancements, and potential future developments in Blood Coagulants areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Blood Coagulants market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Blood Coagulants market is split by Type and by Sale Channel. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Sale Channel in terms of volume and value.
Market segment by Type
Recombinant Coagulation Factor
Plasma Coagulation Factor
Market segment by Sale Channel
Hospital
Pharmacy
Other
Major players covered
Pfizer
Bayer
Novo Nordisk
Takeda
SOBI
Octapharma
CSL
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Blood Coagulants product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Blood Coagulants, with price, sales, revenue and global market share of Blood Coagulants from 2019 to 2024.
Chapter 3, the Blood Coagulants competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Blood Coagulants breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and sale channel, with sales market share and growth rate by type, sale channel, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Blood Coagulants market forecast, by regions, type and sale channel, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Blood Coagulants.
Chapter 14 and 15, to describe Blood Coagulants sales channel, distributors, customers, research findings and conclusion.